Role of positron emission tomography in the management of breast cancer

I C Smith, F J Gilbert

Research output: Contribution to journalLiterature review

4 Citations (Scopus)

Abstract

Positron emission tomography (PET) is an imaging modality that utilises tracers based on biologically important compounds and can be used to study in vivo tissue function. This article reviews the current status of PET imaging in breast disease. The positron emitting glucose analogue F-18-FDG is used to image tissue glycolysis and has been extensively evaluated. Studies have shown that F-18-FDG PET has a high sensitivity and specificity for the detection of primary breast cancers, however its use is not superior that of conventional imaging modalities. Considerable interest is now focussing on the application of PET to non-invasively determine the lymph node status of patients with breast cancer and to predict and evaluate tumour response to chemotherapy. Relatively low cost gamma camera systems are now available that are capable of PET imaging, and thus it may therefore be possible to perform PET imaging in the majority of hospitals. (C) 1999 Harcourt Publishers Ltd.

Original languageEnglish
Pages (from-to)303-310
Number of pages8
JournalBreast
Volume8
Publication statusPublished - 1999

Keywords

  • LYMPH-NODE METASTASES
  • F-18 FLUORODEOXYGLUCOSE
  • GLUCOSE-METABOLISM
  • FDG-PET
  • CHEMOTHERAPY
  • TUMORS
  • AXILLA

Cite this

Smith, I. C., & Gilbert, F. J. (1999). Role of positron emission tomography in the management of breast cancer. Breast, 8, 303-310.

Role of positron emission tomography in the management of breast cancer. / Smith, I C ; Gilbert, F J .

In: Breast, Vol. 8, 1999, p. 303-310.

Research output: Contribution to journalLiterature review

Smith, IC & Gilbert, FJ 1999, 'Role of positron emission tomography in the management of breast cancer', Breast, vol. 8, pp. 303-310.
Smith, I C ; Gilbert, F J . / Role of positron emission tomography in the management of breast cancer. In: Breast. 1999 ; Vol. 8. pp. 303-310.
@article{5e344b06a0f742f3acdaf680efea4c79,
title = "Role of positron emission tomography in the management of breast cancer",
abstract = "Positron emission tomography (PET) is an imaging modality that utilises tracers based on biologically important compounds and can be used to study in vivo tissue function. This article reviews the current status of PET imaging in breast disease. The positron emitting glucose analogue F-18-FDG is used to image tissue glycolysis and has been extensively evaluated. Studies have shown that F-18-FDG PET has a high sensitivity and specificity for the detection of primary breast cancers, however its use is not superior that of conventional imaging modalities. Considerable interest is now focussing on the application of PET to non-invasively determine the lymph node status of patients with breast cancer and to predict and evaluate tumour response to chemotherapy. Relatively low cost gamma camera systems are now available that are capable of PET imaging, and thus it may therefore be possible to perform PET imaging in the majority of hospitals. (C) 1999 Harcourt Publishers Ltd.",
keywords = "LYMPH-NODE METASTASES, F-18 FLUORODEOXYGLUCOSE, GLUCOSE-METABOLISM, FDG-PET, CHEMOTHERAPY, TUMORS, AXILLA",
author = "Smith, {I C} and Gilbert, {F J}",
year = "1999",
language = "English",
volume = "8",
pages = "303--310",
journal = "Breast",
issn = "0960-9776",
publisher = "Churchill Livingstone",

}

TY - JOUR

T1 - Role of positron emission tomography in the management of breast cancer

AU - Smith, I C

AU - Gilbert, F J

PY - 1999

Y1 - 1999

N2 - Positron emission tomography (PET) is an imaging modality that utilises tracers based on biologically important compounds and can be used to study in vivo tissue function. This article reviews the current status of PET imaging in breast disease. The positron emitting glucose analogue F-18-FDG is used to image tissue glycolysis and has been extensively evaluated. Studies have shown that F-18-FDG PET has a high sensitivity and specificity for the detection of primary breast cancers, however its use is not superior that of conventional imaging modalities. Considerable interest is now focussing on the application of PET to non-invasively determine the lymph node status of patients with breast cancer and to predict and evaluate tumour response to chemotherapy. Relatively low cost gamma camera systems are now available that are capable of PET imaging, and thus it may therefore be possible to perform PET imaging in the majority of hospitals. (C) 1999 Harcourt Publishers Ltd.

AB - Positron emission tomography (PET) is an imaging modality that utilises tracers based on biologically important compounds and can be used to study in vivo tissue function. This article reviews the current status of PET imaging in breast disease. The positron emitting glucose analogue F-18-FDG is used to image tissue glycolysis and has been extensively evaluated. Studies have shown that F-18-FDG PET has a high sensitivity and specificity for the detection of primary breast cancers, however its use is not superior that of conventional imaging modalities. Considerable interest is now focussing on the application of PET to non-invasively determine the lymph node status of patients with breast cancer and to predict and evaluate tumour response to chemotherapy. Relatively low cost gamma camera systems are now available that are capable of PET imaging, and thus it may therefore be possible to perform PET imaging in the majority of hospitals. (C) 1999 Harcourt Publishers Ltd.

KW - LYMPH-NODE METASTASES

KW - F-18 FLUORODEOXYGLUCOSE

KW - GLUCOSE-METABOLISM

KW - FDG-PET

KW - CHEMOTHERAPY

KW - TUMORS

KW - AXILLA

M3 - Literature review

VL - 8

SP - 303

EP - 310

JO - Breast

JF - Breast

SN - 0960-9776

ER -